(Total Views: 656)
Posted On: 08/04/2020 10:10:44 PM
Post# of 145900
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The DSMB decision may come down to something as simple as leronlimab in combo with other drugs makes it harder to determine efficacy. Is it leronlimab or the other drugs? Beware of what the FDA offers you it might be a Trojan horse.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)